4th quarter revs up 186%. Almost equal the other quarters combined. Revs climbed from 200,000 to 490,000 http://www.capitalcube.com/blog/index.php/calmare-therapeutics-inc-cttc-us-earnings-analysis-q4-2015-by-the-numbers/ The table below shows the preliminary results and recent trends for key metrics such as revenues and net income growth: 2014-12-31 2015-03-31 2015-06-30 2015-09-30 2015-12-31 Relevant Numbers (Quarterly) Revenues (mil) 0.17 0.02 0.22 0.2 0.49 Revenue Growth (%YOY) -26.92 -91.71 -31.12 -53.02 185.82 Earnings (mil) -0.66 -1 -0.78 -1.06 -0.83 Earnings Growth (%YOY) -8.76 -38.27 1.53 13.53 -25.22 Net Margin (%) -390.62 -5327.87 -355.14 -538.94 -171.14 EPS -0.03 -0.04 -0.03 -0.04 -0.03 Return on Equity (%) N/A N/A N/A N/A N/A Return on Assets (%) -59.28 -91.52 -71.9 -99.47 -78.9